New Data, New Perspectives in Ovarian Cancer: Experts Discuss the Current Paradigm and Long-term Benefits of PARP Inhibitor Therapy

Download All
Gain a deeper understanding of how PARP inhibitors fit into current treatment approaches in ovarian cancer in this on-demand webcast and audio podcast, then download the slides for use in your own presentations.
Nicoletta Colombo, MD

ClinicalThought Commentary

Read this expert commentary to gain practical clinical insights on the current treatment landscape of PARP inhibitors and the role of biomarkers in ovarian cancer.

Nicoletta Colombo, MD Released: November 2, 2021
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings